Speaker illustration

Mr Francois Laliberte

Analysis Group, Montreal (Canada)

Hospitalizations and other healthcare resource utilization among patients with deep vein thrombosis treated with rivaroxaban versus low-molecular-weight heparin and warfarin in the outpatient setting

Event: ESC Congress 2016

Topic: Thrombosis and coagulation

Session: Thrombosis and coagulation


ESC 365 is supported by

logo Novo Nordisk